CAMBRIDGE, Mass., March 11, 2025 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) – announced the initiation of dosing in the global clinical study, TRANSCEND. The Phase 3 study will evaluate the efficacy and safety of the investigational drug felzartamab compared to placebo in adult kidney transplant recipients diagnosed with late antibody-mediated rejection (AMR). TRANSCEND is designed to enroll approximately 120 kidney transplant recipients with late AMR.
Alpha Metallurgical Resources benefits from strong demand for met coal in developing markets like India, which supports long-term revenue growth despite global renewable energy trends. AMR's higher average selling prices and significant share buybacks position it as a more attractive investment compared to peers like BTU and HCC. Despite short-term price fluctuations and long-term renewable energy risks, AMR's robust financials and market position offer a 38.8% upside potential.
Alpha Metallurgical Resources, Inc. is the largest U.S. metallurgical coal miner, facing weak coking coal prices but still generating positive free cash flow. Q4 2024 results showed an $8M EBITDA increase and a minor $2M net loss, with stable sales volumes and slight price declines. AMR is well-capitalized, with $482M in cash and $519M in liquidity.
Alpha Metallurgical Resources, Inc. (NYSE:AMR ) Q4 2024 Earnings Conference Call February 28, 2025 10:00 AM ET Company Participants Emily O'Quinn - SVP-IR and Communications Andy Eidson - CEO Jason Whitehead - President and COO Todd Munsey - CFO Dan Horn - Chief Commercial Officer Conference Call Participants Nathan Martin - The Benchmark Company Nick Giles - B. Riley Operator Greetings, and welcome to the Alpha Metallurgical Resources Fourth Quarter 2024 Results Conference Call.
With 21 producing mines and 9 loading facilities, Alpha Metallurgical accounts for ~20% of U.S. metallurgical coal production. The company exports most of its production through its 65% ownership interest in Dominion Terminal Associates, an export terminal located in Newport News, Virginia. After a historic period of excess profitability, metallurgical coal prices are now under pressure, and Alpha Metallurgical may find itself in a free cash flow neutral position.
Alpha Metallurgical (AMR) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Alpha generated a total of $49 million during 3Q2024. The company currently focuses on the extraction of metallurgical coal, which is mainly exported. Only 29% of production is destined for the US, the remaining 71% is exported to various. When we analyze what happened in 3Q2024, we see that the cash generated by Alpha was $189.5 million, higher than the $138.1 million of 2Q2024.
Here is how Alpha Metallurgical (AMR) and First Majestic Silver (AG) have performed compared to their sector so far this year.
Alpha Metallurgical Resources is a significant player in the met coal industry, crucial for steel production, with a strong export business, especially to India. Despite a stock price drop from $400 to $200, AMR's fundamentals and valuation suggest a potential value opportunity for investors. AMR passes key investment factors: it is an important company, and founder-led with insider alignment. It fails on gross margins and predictable revenue growth due to coal price volatility.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.